Big Move For Ritter Pharmaceuticals, Inc.
Fri, Feb 28, 2020 at 05:30 PM

Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ) jumped higher at $0.69, representing a gain of 143.2%. On Thu 27 Feb 20, RTTR:NASDAQ touched a New 2-Week High of $0.28. From Thu 06 Feb 20, the stock recorded 42.86% Up Days and 26.67% Green Days
About Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ)
Ritter Pharmaceuticals Inc is a specialty pharmaceutical company. it develops therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The company focuses on development and commercialization of RP-G28.
Top 10 Gainers:
- iBio, Inc. (IBIO:NYSEMKT), 183.24%
- Biocept, Inc. (BIOC:NASDAQ), 168.87%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 143.21%
- Altimmune, Inc. (ALT:NASDAQ), 110.23%
- OpGen, Inc. (OPGN:NASDAQ), 66.18%
- Trillium Therapeutics Inc. (TRIL:NASDAQ), 62.9%
- Dynatronics Corporation (DYNT:NASDAQ), 59.34%
- Heat Biologics, Inc. (HTBX:NASDAQ), 54.93%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 54.64%
- Correvio Pharma Corp. (CORV:NASDAQ), 50.82%